Latest Insider Transactions at Windtree Therapeutics Inc (WINT)
This section provides a real-time view of insider transactions for Windtree Therapeutics Inc (WINT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WINDTREE THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WINDTREE THERAPEUTICS INC 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2021
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
1,500
+5.49%
|
$4,500
$3.25 P/Share
|
|
Mar 25
2021
|
John P. Hamill SVP & CFO |
BUY
Open market or private purchase
|
Direct |
1,500
+37.5%
|
$4,500
$3.25 P/Share
|
|
Mar 25
2021
|
Steven Simonson SVP, Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+10.87%
|
$4,500
$3.25 P/Share
|
|
Oct 28
2020
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
250
+1.02%
|
$1,500
$6.56 P/Share
|
|
Oct 23
2020
|
James Huang Director |
BUY
Open market or private purchase
|
Direct |
1,000
+4.55%
|
$6,000
$6.67 P/Share
|
|
Oct 09
2020
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
250
+1.03%
|
$1,250
$5.83 P/Share
|
|
Oct 08
2020
|
Eric Curtis SVP & COO |
BUY
Open market or private purchase
|
Direct |
500
+50.0%
|
$2,500
$5.27 P/Share
|
|
Oct 07
2020
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
250
+1.04%
|
$1,250
$5.17 P/Share
|
|
Oct 07
2020
|
John P. Hamill SVP & CFO |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$5,000
$5.27 P/Share
|
|
May 20
2020
|
Bioengine Capital Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
55,172
+4.26%
|
$386,204
$7.25 P/Share
|
|
May 20
2020
|
Bioengine Capital Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,551,750
-75.0%
|
-
|
|
May 20
2020
|
Center Laboratories, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
55,172
+4.26%
|
$386,204
$7.25 P/Share
|
|
May 20
2020
|
Center Laboratories, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,551,750
-75.0%
|
-
|